TAMARAH JUNGKLAUS: Open Payments
NPI 1255436838 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 14 payments from 6 companies in 2025. Trend: 2023 $91 · 2024 $1,027 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $213 |
| Regeneron Healthcare Solutions, Inc. | 2 | $146 |
| GENZYME CORPORATION | 2 | $62 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Amgen Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, NEFFY, TEZSPIRE, TAKHZYRO.
Industry payments across FL — which companies pay providers there.
